Effects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies

199379 citationsJournal Article

Authors

These findings suggest activity of anti-CD5 IC in active RA and warrant confirmation in a multicenter randomized study (currently underway).

Good health and well-being

Published in: Arthritis & Rheumatism

Volume 36, Issue 5, pp. 620-630

Field-Weighted Citation Impact: 4.91